Literature DB >> 25184163

Salivary: flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis.

Małgorzata Knaś, Anna Zalewska, Napoleon Waszkiewicz, Julita Szulimowska, Janusz Dziezcioł, Stanisław Sierakowski, Danuta Waszkiel.   

Abstract

BACKGROUND: However, there are some informations on the salivary glands involvement in systemic sclerosis, and there is a lack of any data about salivary glands function depending on systemic sclerosis subsets.
METHODS: The unstimulated and stimulated salivary flow, the activity of peroxidase, the total amount of lactoferrin, lysozyme and sIgA were determined in two subgroups of systemic sclerosis and healthy controls.
RESULTS: In the unstimulated saliva of both patients groups, the salivary flow, the output of total protein and peroxidase activity were significantly lower; the total: sIgA and lactoferrin were significantly higher as compared with the control. In the stimulated saliva of the patients with limited form, the total lysozyme and peroxidase activity were significantly higher than in the control. In the stimulated saliva of the patients with diffused form, the salivary flow was significantly lower and the total sIgA and peroxidase activity were significantly higher than in the control.
CONCLUSION: Systemic sclerosis regardless of its subset affects salivary defense system of human unstimulated and stimulated saliva. Patients with the limited form experience the same impairment of the submandibular glands function as compared with patients with the diffused form. Only patients with the diffused form are deficient in respect of stimulated saliva secretion; the parotid glands of the patients with the limited form have a good secretory capacity in comparison with the healthy control.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25184163     DOI: 10.1111/jop.12166

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

Review 1.  Orofacial consequences of systemic sclerosis: A systematic review.

Authors:  Rawen Smirani; Nicolas Poursac; Adrien Naveau; Thierry Schaeverbeke; Raphaël Devillard; Marie-Elise Truchetet
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

2.  Salivary gland involvement and oral health in patients with coeliac disease.

Authors:  Jason Liu; Ann-Kristine Juncker Lundemann; Jesper Reibel; Anne Marie Lynge Pedersen
Journal:  Eur J Oral Sci       Date:  2022-03-05       Impact factor: 2.160

3.  Salivary Secretory Immunoglobulin (SIgA) and Lysozyme in Malignant Tumor Patients.

Authors:  Haiyan Sun; Yong Chen; Xuan Zou; Qihong Li; Huan Li; Yao Shu; Xia Li; Weihong Li; Li Han; Cheng Ge
Journal:  Biomed Res Int       Date:  2016-05-17       Impact factor: 3.411

4.  Oxidative Modification of Biomolecules in the Nonstimulated and Stimulated Saliva of Patients with Morbid Obesity Treated with Bariatric Surgery.

Authors:  Katarzyna Fejfer; Piotr Buczko; Marek Niczyporuk; Jerzy R Ładny; Hady R Hady; Małgorzata Knaś; Danuta Waszkiel; Anna Klimiuk; Anna Zalewska; Mateusz Maciejczyk
Journal:  Biomed Res Int       Date:  2017-12-31       Impact factor: 3.411

Review 5.  Salivary Biomarkers in Systemic Sclerosis Disease.

Authors:  Zeineb Zian; Joaira Bakkach; Amina Barakat; Naima Ghailani Nourouti; Mohcine Bennani Mechita
Journal:  Biomed Res Int       Date:  2018-03-12       Impact factor: 3.411

6.  Reduced salivary flow and caries status are correlated with disease activity and severity in patients with diffuse cutaneous systemic sclerosis.

Authors:  Katica Parat; Mislav Radić; Dijana Perković; Dolores Biočina Lukenda; Dusanka Martinović Kaliterna
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

7.  Cytokine/Chemokine/Growth Factor Profiles Contribute to Understanding the Pathogenesis of the Salivary Gland Dysfunction in Euthyroid Hashimoto's Thyroiditis Patients.

Authors:  K Morawska; M Maciejczyk; S Zięba; Ł Popławski; A Kita-Popławska; J Krętowski; A Zalewska
Journal:  Mediators Inflamm       Date:  2021-07-11       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.